- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Enrollment Up, Premiums Down in Medicare Advantage Plans
Enrollment in Medicare Advantage plans has risen by 10% in the past year and premiums have dropped by 7%, despite billions of dollars in reimbursement cuts to the program, HHS officials announced Wednesday.
Enrollment in the plans -- which are run by private insurers -- has grown from 11.7 million Medicare beneficiaries in 2011 to 12.8 million in 2012, a 17% increase. The average premium has dropped by more than $2 per month since last year and now averages $31.54 per month, according to the
Department of Health and Human Services (HHS).
Medicare Advantage plans were targeted by Democrats as an area in which to cut spending during debate over the Affordable Care Act (ACA), in part because the private plans used to be paid about 13% more than traditional Medicare plans. A recent Government Accountability Office study found the government overpaid private insurance companies administering Medicare Advantage plans by as much as $3.1 billion in 2010.
Read more at: http://tinyurl.com/7vg5nwq
Source: MedPage Today
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
